Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcoholism | 23 | 2022 | 1109 | 1.710 |
Why?
|
| Naltrexone | 10 | 2020 | 195 | 1.420 |
Why?
|
| Alcohol Drinking | 12 | 2018 | 805 | 0.870 |
Why?
|
| Antipsychotic Agents | 3 | 2017 | 247 | 0.480 |
Why?
|
| Catechol O-Methyltransferase | 3 | 2022 | 31 | 0.440 |
Why?
|
| Aripiprazole | 4 | 2017 | 43 | 0.410 |
Why?
|
| Quinolones | 2 | 2010 | 60 | 0.410 |
Why?
|
| Piperazines | 2 | 2010 | 206 | 0.380 |
Why?
|
| Narcotic Antagonists | 5 | 2017 | 184 | 0.340 |
Why?
|
| Ondansetron | 1 | 2008 | 13 | 0.330 |
Why?
|
| Receptors, Opioid, mu | 3 | 2020 | 70 | 0.330 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 3 | 2020 | 82 | 0.330 |
Why?
|
| Serotonin Antagonists | 1 | 2008 | 31 | 0.320 |
Why?
|
| Basal Ganglia | 1 | 2008 | 45 | 0.320 |
Why?
|
| Narcotics | 1 | 2008 | 65 | 0.320 |
Why?
|
| Models, Theoretical | 1 | 2008 | 384 | 0.270 |
Why?
|
| Cues | 6 | 2017 | 654 | 0.250 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2021 | 208 | 0.240 |
Why?
|
| Impulsive Behavior | 2 | 2017 | 85 | 0.220 |
Why?
|
| Environment | 1 | 2002 | 115 | 0.210 |
Why?
|
| Double-Blind Method | 7 | 2021 | 1737 | 0.210 |
Why?
|
| Ethanol | 6 | 2022 | 892 | 0.210 |
Why?
|
| Substance Withdrawal Syndrome | 3 | 2021 | 435 | 0.200 |
Why?
|
| Behavior, Addictive | 1 | 2004 | 317 | 0.190 |
Why?
|
| Adult | 19 | 2021 | 21375 | 0.190 |
Why?
|
| Alcohol Deterrents | 2 | 2018 | 86 | 0.190 |
Why?
|
| Gyrus Cinguli | 1 | 2021 | 113 | 0.190 |
Why?
|
| Alcohol Abstinence | 1 | 2020 | 23 | 0.180 |
Why?
|
| Male | 26 | 2021 | 37281 | 0.180 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2020 | 128 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2020 | 627 | 0.170 |
Why?
|
| Female | 21 | 2021 | 38015 | 0.160 |
Why?
|
| Glutamic Acid | 1 | 2021 | 332 | 0.160 |
Why?
|
| Self-Control | 1 | 2017 | 9 | 0.150 |
Why?
|
| Dopamine Agonists | 1 | 2017 | 68 | 0.150 |
Why?
|
| Receptors, GABA-A | 1 | 2016 | 89 | 0.130 |
Why?
|
| Middle Aged | 14 | 2021 | 21119 | 0.130 |
Why?
|
| Humans | 23 | 2022 | 68525 | 0.130 |
Why?
|
| Nicotine | 1 | 2018 | 350 | 0.130 |
Why?
|
| Motivation | 3 | 2017 | 561 | 0.120 |
Why?
|
| Analysis of Variance | 4 | 2004 | 1039 | 0.120 |
Why?
|
| Piracetam | 3 | 1988 | 10 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2017 | 2222 | 0.120 |
Why?
|
| Brain | 5 | 2017 | 2175 | 0.110 |
Why?
|
| Social Behavior | 2 | 2004 | 164 | 0.110 |
Why?
|
| Smoking | 2 | 2018 | 1449 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2012 | 220 | 0.100 |
Why?
|
| Pyrrolidinones | 2 | 1988 | 15 | 0.100 |
Why?
|
| Glutamates | 2 | 1987 | 41 | 0.090 |
Why?
|
| Photic Stimulation | 2 | 2008 | 229 | 0.090 |
Why?
|
| Treatment Outcome | 7 | 2020 | 7028 | 0.090 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 1851 | 0.090 |
Why?
|
| Social Control, Informal | 1 | 2008 | 8 | 0.080 |
Why?
|
| Picolines | 1 | 1988 | 8 | 0.080 |
Why?
|
| Meclofenoxate | 1 | 1987 | 1 | 0.080 |
Why?
|
| Glycolates | 1 | 1987 | 2 | 0.080 |
Why?
|
| Tranquilizing Agents | 1 | 1987 | 7 | 0.080 |
Why?
|
| Pharmacogenomic Variants | 2 | 2017 | 15 | 0.080 |
Why?
|
| Association Learning | 1 | 1987 | 36 | 0.080 |
Why?
|
| Patient Compliance | 2 | 2007 | 402 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 1745 | 0.080 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2008 | 257 | 0.070 |
Why?
|
| Psychotropic Drugs | 1 | 1987 | 83 | 0.070 |
Why?
|
| Affect | 1 | 2008 | 218 | 0.070 |
Why?
|
| Alcoholic Intoxication | 1 | 1987 | 61 | 0.070 |
Why?
|
| Young Adult | 5 | 2018 | 5708 | 0.070 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2007 | 60 | 0.070 |
Why?
|
| Cerebrovascular Circulation | 1 | 2008 | 296 | 0.070 |
Why?
|
| Sleep | 1 | 2008 | 263 | 0.070 |
Why?
|
| Learning | 2 | 1987 | 186 | 0.070 |
Why?
|
| Amines | 1 | 2007 | 98 | 0.070 |
Why?
|
| Oxygen | 1 | 2008 | 386 | 0.070 |
Why?
|
| Alcohol-Related Disorders | 1 | 2007 | 95 | 0.070 |
Why?
|
| Antioxidants | 1 | 1987 | 304 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2007 | 223 | 0.060 |
Why?
|
| Dopamine | 2 | 2022 | 474 | 0.060 |
Why?
|
| Aged | 5 | 2018 | 14842 | 0.060 |
Why?
|
| Brain Mapping | 3 | 2017 | 531 | 0.060 |
Why?
|
| Dysthymic Disorder | 1 | 2003 | 3 | 0.060 |
Why?
|
| Sertraline | 1 | 2003 | 62 | 0.060 |
Why?
|
| Catechol O-Methyltransferase Inhibitors | 1 | 2022 | 5 | 0.050 |
Why?
|
| Antidepressive Agents | 1 | 2003 | 216 | 0.050 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2021 | 27 | 0.050 |
Why?
|
| Central Nervous System Depressants | 2 | 2017 | 182 | 0.050 |
Why?
|
| Cognition | 1 | 2004 | 512 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2004 | 467 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2003 | 438 | 0.040 |
Why?
|
| Sialoglycoproteins | 1 | 2018 | 24 | 0.040 |
Why?
|
| Genotype | 1 | 2020 | 785 | 0.040 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2017 | 10 | 0.040 |
Why?
|
| Minisatellite Repeats | 1 | 2017 | 16 | 0.040 |
Why?
|
| Transferrin | 1 | 2018 | 94 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2018 | 289 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2017 | 109 | 0.040 |
Why?
|
| Rats | 5 | 1988 | 5300 | 0.040 |
Why?
|
| Deanol | 2 | 1987 | 2 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2017 | 249 | 0.040 |
Why?
|
| Homozygote | 1 | 2016 | 119 | 0.030 |
Why?
|
| Visual Perception | 1 | 2017 | 124 | 0.030 |
Why?
|
| Self Administration | 1 | 2017 | 419 | 0.030 |
Why?
|
| Craving | 1 | 2017 | 200 | 0.030 |
Why?
|
| Reward | 1 | 2017 | 201 | 0.030 |
Why?
|
| Alleles | 1 | 2016 | 386 | 0.030 |
Why?
|
| Time Factors | 5 | 2004 | 4655 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 1 | 2012 | 13 | 0.030 |
Why?
|
| Amnesia | 3 | 1987 | 17 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 1593 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2005 | 951 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 2093 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 301 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 3256 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2004 | 1548 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 1027 | 0.020 |
Why?
|
| Drug Combinations | 2 | 1987 | 304 | 0.020 |
Why?
|
| Emotions | 2 | 1987 | 244 | 0.020 |
Why?
|
| Somatosensory Cortex | 1 | 1988 | 22 | 0.020 |
Why?
|
| Corpus Striatum | 1 | 2010 | 278 | 0.020 |
Why?
|
| Nicotinic Acids | 1 | 1987 | 5 | 0.020 |
Why?
|
| Hydroxybutyrates | 1 | 1987 | 4 | 0.020 |
Why?
|
| Animals | 5 | 1988 | 20877 | 0.020 |
Why?
|
| Sensory Thresholds | 1 | 1987 | 50 | 0.020 |
Why?
|
| Riboflavin | 1 | 2007 | 15 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1987 | 137 | 0.020 |
Why?
|
| Aggression | 1 | 1987 | 98 | 0.020 |
Why?
|
| Sample Size | 1 | 2007 | 79 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 1987 | 79 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 1987 | 95 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2007 | 107 | 0.020 |
Why?
|
| Electroencephalography | 1 | 1988 | 418 | 0.020 |
Why?
|
| Pyridines | 1 | 1987 | 261 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 8903 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 1984 | 30 | 0.020 |
Why?
|
| Dissociative Disorders | 1 | 1984 | 16 | 0.020 |
Why?
|
| Hippocampus | 1 | 1988 | 471 | 0.020 |
Why?
|
| Ethanolamines | 1 | 1984 | 33 | 0.020 |
Why?
|
| Alcoholic Beverages | 1 | 2004 | 18 | 0.020 |
Why?
|
| Alcoholics Anonymous | 1 | 2003 | 13 | 0.020 |
Why?
|
| Rest | 1 | 2004 | 78 | 0.010 |
Why?
|
| Pain | 1 | 1987 | 472 | 0.010 |
Why?
|
| Beverages | 1 | 2004 | 50 | 0.010 |
Why?
|
| Demography | 1 | 2004 | 279 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2005 | 339 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 2798 | 0.010 |
Why?
|
| Conditioning, Classical | 2 | 1985 | 57 | 0.010 |
Why?
|
| Risk Factors | 1 | 2004 | 5719 | 0.010 |
Why?
|
| Escape Reaction | 1 | 1985 | 10 | 0.000 |
Why?
|
| Memory | 1 | 1985 | 214 | 0.000 |
Why?
|
| Extinction, Psychological | 1 | 1985 | 240 | 0.000 |
Why?
|
| Behavior, Animal | 1 | 1984 | 470 | 0.000 |
Why?
|
| Mice | 1 | 1985 | 8472 | 0.000 |
Why?
|